| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Gabapentin | FAERS: 3 | US FAERS | |
| 2 | Methotrexate | FAERS: 3 | US FAERS | |
| 3 | Zoledronic Acid | FAERS: 3 | US FAERS | |
| 4 | Iloprost | FAERS: 2 | US FAERS | |
| 5 | Pamidronate | FAERS: 2 | US FAERS | |
| 6 | Thyroxine | FAERS: 2 | US FAERS | |
| 7 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 8 | Diclofenac | FAERS: 1 | US FAERS | |
| 9 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Irbesartan | FAERS: 1 | US FAERS | |
| 11 | Levofloxacin | FAERS: 1 | US FAERS | |
| 12 | Lidocaine | FAERS: 1 | US FAERS | |
| 13 | Minoxidil | FAERS: 1 | US FAERS | |
| 14 | NuvaRing | FAERS: 1 | US FAERS | |
| 15 | Olanzapine | FAERS: 1 | US FAERS | |
| 16 | PCI 32765 | FAERS: 1 | US FAERS | |
| 17 | Paroxetine | FAERS: 1 | US FAERS | |
| 18 | Pregabalin | FAERS: 1 | US FAERS | |
| 19 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 20 | Vilazodone Hydrochloride | FAERS: 1 | US FAERS | |
| 21 | apixaban | FAERS: 1 | US FAERS | |
| 22 | apremilast | FAERS: 1 | US FAERS | |
| 23 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 24 | etonogestrel | FAERS: 1 | US FAERS | |
| 25 | teriflunomide | FAERS: 1 | US FAERS | |
| 26 | 5-O-[1-[3,3-Diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydron;chloride | OFFSIDES | ||
| 27 | Bupivacaine | OFFSIDES | ||
| 28 | Indomethacin | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Ketotifen | OFFSIDES | ||
| 30 | Pamidronate | OFFSIDES | ||
| 31 | Piroxicam | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.